These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16734496)

  • 1. Antioxidants in multiple sclerosis: do they have a role in therapy?
    Carlson NG; Rose JW
    CNS Drugs; 2006; 20(6):433-41. PubMed ID: 16734496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria-targeted Antioxidants as a Prospective Therapeutic Strategy for Multiple Sclerosis.
    Fetisova E; Chernyak B; Korshunova G; Muntyan M; Skulachev V
    Curr Med Chem; 2017; 24(19):2086-2114. PubMed ID: 28302008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oxidative stress in multiple sclerosis].
    Miller E; Mrowicka M; Zołyński K; Kedziora J
    Pol Merkur Lekarski; 2009 Dec; 27(162):499-502. PubMed ID: 20120717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant therapy in multiple sclerosis.
    Mirshafiey A; Mohsenzadegan M
    Immunopharmacol Immunotoxicol; 2009; 31(1):13-29. PubMed ID: 18763202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in antioxidative therapy of multiple sclerosis.
    Miller E; Wachowicz B; Majsterek I
    Curr Med Chem; 2013; 20(37):4720-30. PubMed ID: 23834174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy.
    Gilgun-Sherki Y; Melamed E; Offen D
    J Neurol; 2004 Mar; 251(3):261-8. PubMed ID: 15015004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis.
    Adamczyk B; Adamczyk-Sowa M
    Oxid Med Cell Longev; 2016; 2016():1973834. PubMed ID: 27829982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical changes in multiple sclerosis pathogenesis.
    van Horssen J; Witte ME; Schreibelt G; de Vries HE
    Biochim Biophys Acta; 2011 Feb; 1812(2):141-50. PubMed ID: 20600869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis.
    Miller ED; Dziedzic A; Saluk-Bijak J; Bijak M
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31284389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidants and polyunsaturated fatty acids in multiple sclerosis.
    van Meeteren ME; Teunissen CE; Dijkstra CD; van Tol EA
    Eur J Clin Nutr; 2005 Dec; 59(12):1347-61. PubMed ID: 16118655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis.
    Wang P; Xie K; Wang C; Bi J
    Eur Neurol; 2014; 72(3-4):249-54. PubMed ID: 25277682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative/Nitroxidative Stress and Multiple Sclerosis.
    Tobore TO
    J Mol Neurosci; 2021 Mar; 71(3):506-514. PubMed ID: 32767188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis.
    Nijland PG; Witte ME; van het Hof B; van der Pol S; Bauer J; Lassmann H; van der Valk P; de Vries HE; van Horssen J
    Acta Neuropathol Commun; 2014 Dec; 2():170. PubMed ID: 25492529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Multiple Sclerosis Modulatory Potential of Natural Multi-Targeting Antioxidants.
    Theodosis-Nobelos P; Rekka EA
    Molecules; 2022 Dec; 27(23):. PubMed ID: 36500494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric acid in multiple sclerosis.
    Koch M; De Keyser J
    Neurol Res; 2006 Apr; 28(3):316-9. PubMed ID: 16687059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis?
    Gonsette RE
    Mult Scler; 2008 Jan; 14(1):22-34. PubMed ID: 17881394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights in the mechanisms of impaired redox signaling and its interplay with inflammation and immunity in multiple sclerosis.
    Michaličková D; Šíma M; Slanař O
    Physiol Res; 2020 Feb; 69(1):1-19. PubMed ID: 31852206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: What is the evidence?
    Sorce S; Stocker R; Seredenina T; Holmdahl R; Aguzzi A; Chio A; Depaulis A; Heitz F; Olofsson P; Olsson T; Duveau V; Sanoudou D; Skosgater S; Vlahou A; Wasquel D; Krause KH; Jaquet V
    Free Radic Biol Med; 2017 Nov; 112():387-396. PubMed ID: 28811143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demyelination: the role of reactive oxygen and nitrogen species.
    Smith KJ; Kapoor R; Felts PA
    Brain Pathol; 1999 Jan; 9(1):69-92. PubMed ID: 9989453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular basis of neurodegeneration in multiple sclerosis.
    Lassmann H; van Horssen J
    FEBS Lett; 2011 Dec; 585(23):3715-23. PubMed ID: 21854776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.